Where therapeutic value and clinical effectiveness is determined as a result of conducting clinical trials, we offer expertise and support in conducting health technology assessments (HTA) and budget impact analyses taking into account both direct and indirect effects in a systematic, transparent, unbiased, robust manner.
For more information on the importance and handling of real-world data in HTA’s, check our interactive dashboard below. You can choose between Dutch (Nederlands) and French (Français) in the upper left corner or by switching between the 2 dashboard pages. The APR-DRG filter can be changed to view more information.
